Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.
- NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_assertion description "[Given that young children with VWD type 3 might carry deletions of VWF gene that predispose to the alloantibodies to VWF, every new child with VWD type 3 should be investigated intensively for VWF gene deletions before starting extensive therapy with exogenous VWF concentrates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.
- NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_assertion evidence source_evidence_literature NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.
- NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_assertion SIO_000772 16977566 NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.
- NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_assertion wasDerivedFrom befree-20140225 NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.
- NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_assertion wasGeneratedBy ECO_0000203 NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP368813.RA3m_us5HEe6aHEOcH7aTW0J-pcTMzMLQTxTCJd-4EBaQ130_provenance.